You are here: Industry Insights > MHRA

News List

Updated restrictions announced for multiple sclerosis treatment europeanpharmaceuticalreview
March 11, 2020
A revised indication, additional contraindications and strengthened monitoring requirements has been recommended for Lemtrada (alemtuzumab) following a review.
MHRA announces two medicine recalls europeanpharmaceuticalreview
March 11, 2020
The Medicines and Healthcare products Regulatory Agency has issed two alerts for medicine recalls in the UK due to out of specification dissolution results and an error in decommissioning.
3.5 million unlicensed erection pills seized in the UK in 2019 europeanpharmaceuticalreview
March 09, 2020
The UK MHRA has announced that the approximately 3.5 million unlicensed erection pills seized last year are worth more than £10 million.
MHRA approves cerebral palsy spasticity drug to treat children europeanpharmaceuticalreview
January 09, 2020
Dysport®, a therapy for spasticity in cerebral palsy patients has been granted a license update to treat children aged two years and older.
MHRA grants licence update for Ipsen’s Dysport pharmaceutical-technology
January 09, 2020
UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a licence update for Ipsen’s Dysport.
MHRA announces recall of Medley Pharma ranitidine tablets europeanpharmaceuticalreview
December 23, 2019
The UK MHRA has issued a recall of two ranitidine products from Medley Pharma as a precautionary measure due to possible contamination.
Parexel Adds Experts to Regulatory Consulting Group ContractPharma
December 11, 2019
Four new hires from U.S. FDA and MHRA will serve as technical vice presidents.
MHRA updates biologic quality guidance document europeanpharmaceuticalreview
September 19, 2019
The UK Medicine and Healthcare products Regulatory Agency has released a revision to its standards for ensuring high quality of biologic products.
Jet-lag medication approved by MHRA europeanpharmaceuticalreview
July 02, 2019
The MHRA has given marketing authorisation for short-term jet-lag therapy in adults.
MHRA issues recall of paracetamol tablets europeanpharmaceuticalreview
June 20, 2019
A drug alert has been issued for two batches of paracetamol tablets found to have discolourations due to fungi.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page